Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Niralee Patel"'
Autor:
Niralee Patel, MD, Joshua L. Rein, DO, Luis Sanchez-Russo, MD, Jonathan Winston, MD, Jaime Uribarri, MD
Publikováno v:
Kidney Medicine, Vol 3, Iss 1, Pp 129- (2021)
Externí odkaz:
https://doaj.org/article/a9309b8359154845aaa93db354ea2d67
Publikováno v:
Kidney Medicine, Vol 2, Iss 5, Pp 668-669 (2020)
Externí odkaz:
https://doaj.org/article/c7b62a5162c0440eb8ca1ca78ff5f242
Publikováno v:
Advances in Kidney Disease and Health. 30:102-109
Autor:
Niralee Patel, Mrinalini Nair
Publikováno v:
Journal of Microbiology. 59:920-930
The pathogenesis of Staphylococcus aureus, from local infections to systemic dissemination, is mediated by a battery of virulence factors that are regulated by intricate mechanisms, which include regulatory proteins and small RNAs (sRNAs) as key regu
Autor:
Staci Leisman, Niralee Patel
Publikováno v:
Advances in chronic kidney disease. 29(6)
Autor:
Girish N. Nadkarni, Niralee Patel
Publikováno v:
Cardiology Clinics. 37:327-334
Ethnic disparities in health outcomes exist among multiple complex diseases especially cardiovascular disease, hypertension, and kidney disease. Recent discoveries in genetics have taught us that these disparities go beyond environmental and socioeco
Autor:
John M. Basgen, Niralee Patel, Ke Zen, Bingbing Zhu, Katalin Susztak, Zhengzi Yi, John Cijiang He, Paolo Cravedi, Song Jiang, Evren U. Azeloglu, Osama El Shamy, Hao Wang, Tomohito Doke, Vivette D. D'Agati, S. G. Coca, Zhihong Liu, Lewis Kaufman, Weijia Zhang, Aili Cao, Kirk N. Campbell, Morad Asadi, Barbara Murphy, Madhav C. Menon, Jianhua Li
Publikováno v:
Journal of Clinical Investigation. 131
Dachshund homolog 1 (DACH1), a key cell-fate determinant, regulates transcription by DNA sequence-specific binding. We identified diminished Dach1 expression in a large-scale screen for mutations that convert injury-resistant podocytes into injury-su
Publikováno v:
Kidney360
In recent robust randomized control trials (RCTs), sodium-glucose cotransporter 2 (SGLT2) inhibitors (empagliflozin, canagliflozin, dapagliflozin, and ertugliflozin) have been shown to dramatically decrease both kidney and cardiovascular (CV) adverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2721c4aa7d2dd106fa69f4491782bfd1
https://europepmc.org/articles/PMC8786095/
https://europepmc.org/articles/PMC8786095/
Autor:
Alexey Zendel, Andrew D. Santeusanio, Arjun Bhansali, Graciela De Boccardo, Madhav C. Menon, Ron Shapiro, Samantha E. Jacobs, Samira S. Farouk, Yaniv Fenig, Meenakshi Rana, Fasika M Tedla, Veronica Delaney, Sarah Taimur, Dallas Dunn, Ahmad Mahamid, Caroline Liu, Fahima Mahir, Vinita Sehgal, Niralee Patel, Sander Florman, Timothy Sullivan, Emily Baneman, Rafael Khaim
Publikováno v:
Clinical Transplantation
The influence of patient characteristics and immunosuppression management on COVID‐19 outcomes in kidney transplant recipients (KTRs) remains uncertain. We performed a single‐center, retrospective review of all adult KTRs admitted to the hospital
Autor:
Mohamed Halim Abdelbaset, Shuchita Sharma, Linda Chenet, Robert A. Lookstein, Noah A. Cohen, David Lee, Osama El Shamy, Joji Tokita, Jaime Uribarri, Niralee Patel
Publikováno v:
J Am Soc Nephrol
No abstract available Keywords: COVID-19; acute renal failure; dialysis; peritoneal dialysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d1751b0bf42e93dc3b886c544fb81a1
https://europepmc.org/articles/PMC7460897/
https://europepmc.org/articles/PMC7460897/